One of the fundamental challenges in
treating brain cancer with drugs is what is known as the blood - brain barrier that separates circulating blood from the brain extracellular fluid in the central nervous system.
Other research at U-M is developing new options
for treating brain cancer through immunotherapy — harnessing the immune system to attack cancer cells once an injection of a particular gene therapy is delivered into the brain tumor.
«We also identified a way to de-stabilize the SOX9 protein
by treating the brain cancer cells with small molecular drugs, which made them less resistant to chemotherapy again,» says Olle Sangfelt, the other principal investigator of the study and research group leader at Karolinska Institutet.
Bottom Line: Young mice that received molecularly targeted therapies used to
treat brain cancer in human patients sustained cognitive and behavioral deficits, but the deficits were largely reversible through environmental stimulation and physical exercise.
One of the fundamental challenges in
treating brain cancer with drugs is what is known as the blood - brain barrier, a membrane that separates circulating blood from the brain extracellular fluid in the central nervous system.
After graduating from college, he helped launch a biotech company that produced a drug to
treat brain cancer; later, he launched a start - up that automated charitable giving programs for major corporations.
«Boosting immune system to
treat brain cancer.»
«Counterintuitive approach to
treating a brain cancer.»
This revolutionary technique, originally developed to
treat brain cancer, relies on highly advanced imaging, treatment planning and radiation delivery technology to deliver an extremely potent dose with extreme precision from multiple angles and it has been shown to offer better cure rates for many cancers, particularly in cancers that have spread (metastasized).
Chemotherapy generally has not been used to
treat brain cancer, because of the blood - brain barrier that exists between the bloodstream and the cerebrospinal fluid surrounding the brain.
A chemotherapy drug used to
treat brain cancer may increase vulnerability to depression by stopping new brain cells from growing, according to a new King's College London study out today in Translational Psychiatry.